Lv11
30 积分 2025-11-19 加入
Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial
1小时前
已完结
Adalimumab Monotherapy vs Adalimumab With Methotrexate for Psoriasis
2个月前
已完结
Target Trial Emulations of Sodium‐Glucose Cotransporter 2 Inhibitors in Systemic Lupus Erythematosus
2个月前
已完结
Islet-after-kidney transplantation versus kidney alone in kidney transplant recipients with type 1 diabetes (KAIAK): a population-based target trial emulation in France
2个月前
已完结
GLP-1 Receptor Agonists and Cancer Risk in Adults With Obesity
2个月前
已完结
皖公网安备34019202002308
